PLx Pharma Inc. Common Stock

Compare this stock

PLXP Stock Report Card

Today's performance

37%

Performance

Score:

10/100

PLXP returned -96.94% in the last 12 months. Based on the other stocks in its sector with an average return of -31.58%, its performance is below average giving it a grade of 10 of 100.

Forecast

Score:

75/100

1 analysts offer 12-month price forecasts for PLXP. Together, they have an average target of 0, the most optimistic forecast put PLXP at 0 within 12-months and the most pessimistic has PLXP at 0.

Sentiment

Score:

71/100

PLXP had a bullish sentiment score of 70.81% across Twitter and StockTwits over the last 12 months. It had an average of 9.26 posts, 0.97 comments, and 3.56 likes per day.

Technicals

Score:

10/100

PLXP receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

Earnings

Score:

10/100

PLXP has missed earnings 9 times in the last 20 quarters.

Profit

Score:

41/100

Out of the last 20 quarters, PLXP has had 8 profitable quarters and has increased their profits year over year on 6 of them.

Volatility

Score:

30/100

PLXP has had a lower than average amount of volatility over the last 12 months giving it a grade of 29 of 100.

PLx Pharma Inc. Common Stock Summary

Nasdaq / PLXP

Healthcare

Drug Manufacturers—Specialty & Generic

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

Power up your portfolio